Wuzhou Company's equipment had already produced related products before Dr. Zhang's results came out. In early May, the first prototype was released.
After that, the application was submitted to the National Medical Products Administration normally.
Before Wu Zhou started to make efforts to speed up the approval, the leaders of the relevant departments took the initiative to contact him after seeing the detailed technical details.
It will then be listed as a key approval project and given priority for approval.
Of course, the relevant departments of the company will fully cooperate, provide sufficient materials and data, and actively communicate with the approval personnel.
As for the information, because of the AI assistance, most of it was done in one pass except for a few parts, and the efficiency was unexpectedly high.
However, subsequent rounds of rigorous technical reviews and safety assessments will be required.
This includes the equipment 'purchasing' of top hospitals like Liu Yang and Zhang Wei.
In fact, it is a prototype used for actual testing and safety evaluation.
Relevant data will be compiled regularly, and the Food and Drug Administration is also paying close attention to it.
In early June, after nearly one million data had been verified, the Food and Drug Administration's approval was accelerated again.
On the other hand, the equipment of Aiying Group has also been noticed by some other departments of the country.
Because of the current slow speed of nucleic acid testing and the problem of testing accuracy errors, it is easy for missed diagnoses to occur. In order to avoid this problem, we can only focus on sealing.
Then there are one or two people who occasionally go to the society.
It’s time-consuming, labor-intensive, and extremely expensive.
Now the equipment of Aiying Medical needs to be accurate and accurate, convenient and convenient, and efficient. One piece of equipment can support more than ten PCR equipment.
Acting on the urgent matter, the relevant departments directly ordered 10,000 units of equipment before the product had obtained marketing approval and distributed them to some major provinces and cities with high population mobility.
On the other hand, approvals are accelerated in China, and the same is true abroad, with breakthrough technologies, special approvals, accelerated approvals, accelerated listings, etc.
The speed is no slower than in China.
Moreover, the actual market demand abroad, at least for now, is much greater than that at home.
Because of this CRISPR nucleic acid detection equipment, Aiying Group has become quite popular during this period.
"MD, Wu Zhou is so lucky. He can catch up with him no matter what." Someone said angrily.
Envy, jealousy.
Because the market demand at home and abroad is really huge. The domestic market demand alone is at least hundreds of thousands of units, which is worth tens of billions.
Of course, in addition to this, there is another piece of news that has once again aroused heated discussion.
“Recently, an inactivated mask vaccine developed by Huaxia Aiying Biological Company has achieved encouraging results in phase 2 clinical trials. According to reports, the vaccine uses inactivated mask viruses as antigens and can induce the body to produce anti- Neutralizing antibodies against mask viruses.
The phase 2 clinical trial recruited a total of 2,000 healthy volunteers and randomly divided them into two groups, of which 1,000 received the inactivated mask vaccine and the other 1,000 received a placebo. The trial results showed that more than 95% of the volunteers who received the inactivated mask vaccine produced high levels of neutralizing antibody titers after vaccination, and no serious adverse reactions occurred in any volunteers.
It is worth noting that inactivated mask vaccine is a traditional and mature vaccine technology, and its main advantage is that it can retain the natural virus structure and immunogenicity. The success of this trial proves that the inactivated mask vaccine has good efficacy and safety in preventing and controlling mask virus infections.
Scientists said that the next step will be to conduct a larger-scale Phase 3 clinical trial to further verify the safety and effectiveness of the vaccine in different populations, regions and mutant strains, and to optimize its preparation process and quality standards to provide global defense against the virus. Mask viruses offer new weapons. "
As soon as this report comes out.
A kind of melon-eaters were even more dumbfounded.
"Is Aiying Biotechnology related to the mask virus?"
"Who is Aiying Biotech? Why have I never heard of it? Do they have formal qualifications and approvals?"
"Aiying Biotech and Aiying Medical are both subsidiaries of Aiying Group."
"Did I read that correctly? It's Aiying again. They're both from the Aiying Group? Is there another Aiying Biotechnology company in China?"
"Stop saying anything. Send me the stock code. I want to go all in."
"It's great! The success of the inactivated mask vaccine adds confidence to our victory in the battle against the epidemic! Thank you to Huaxia Aiying Biotech and all the scientists who participated in the research and development and trials!"
"Haha, the whole thing is just wandering around in old technology. This should be the reason why our technology has always lagged behind Europe and the United States. The mrna vaccine is the future trend. We should keep up with the times and we should reflect."
"Why don't you reflect on yourself? You didn't get admitted to Tsinghua University and Peking University. You didn't make money. You didn't take up the banner of China's scientific research."
"Everything is reflection. You know how to let others reflect, have you reflected on it yourself? What's wrong with the inactivated vaccine? Such a safe traditional vaccine route, why can't it be used? Just because Europe and the United States use the MRNA vaccine route. Is that good? So far, not a single product of the mrna vaccine route has been launched. This kind of vaccine that the whole people needs is tested with this kind of technical vaccine that has not yet been verified for safety? Haha."
"This trial only has 2,000 people, which is not large enough."
"Are you really stupid or are you pretending to be stupid? 2,000 people is still a small number? Phase 2 is the second clinical phase, and there is still phase 3. Phase 3 is the large scale."
"Mr. Wu, you can't make a lot of money like this. The capital market is the way to go. Hurry up and go public."
"+1"
In Pfizer CEO's office, Smith is currently browsing industry news.
As a company manager, you must not only know the internal situation of the company.
I slid my fingers as usual and looked at the latest industry news, but my fingers suddenly stopped.
Smith picked up the phone at hand and called the marketing manager Mike. "Mike, come right now!"
"Okay, boss. What happened?" Mike was surprised after receiving the call. He is discussing the recent market situation with his colleagues in the office and preparing to formulate the next stage of marketing strategy.
"Stop asking, come here quickly!" Jack Smith urged, and then hung up the phone.
Mike felt uneasy and hurried out of the office. "Sorry, everyone, I have to go. My boss is looking for me," he said to his colleagues.
"What's wrong? Is everything okay?" Colleagues looked at him curiously.
"I don't know, he sounds very serious. I hope it's not bad news." Mike shook his head and said helplessly.
Mike walked to Smith's office door and knocked on the door. "Boss, I'm here. Can you come in?"
"Come in, close the door." Smith's voice was a little low, but his face was still serious.
Mike walked into the office "Boss, what's wrong? You look unhappy."
"Look at this and tell me what you think." Smith didn't answer him, just pointed to his computer and told him to look at it for himself.
Mike glanced at his boss in confusion, and then walked over. After a moment, his face became serious, and about three minutes later, he showed a look of surprise.
"Do you understand what this means to our company?" Smith frowned.
Mike thought for a moment and then said seriously: "This is indeed a trouble. How can their research and development progress be so fast? Even if it is accelerated approval, the second phase of clinical trials should be completed in a few months, unless they are in the early stage." The research and development is going extremely smoothly, or it may have started earlier.”
"Or they have some secret partners or investors that we don't know about, or maybe they have some breakthrough technologies or methods that we haven't heard of." Mike frowned and said in confusion.
"We need to investigate these things carefully. The most important thing is that their products have already entered the third phase, several months faster than ours." Smith shook his head and said.
"Yes, according to the news, this vaccine is an inactivated vaccine. This is a traditional and mature technology. It is easier to gain the trust and approval of the public and regulatory agencies than our company's current mRNA vaccine. And it is inactivated. Live vaccines can be cheaper and easier to store and transport. This means that if they can successfully launch their products first, it will be really bad for us." Mike probably guessed some possibilities in his mind. After all, the problem of masks is getting more and more serious. Many countries are looking forward to developing a vaccine as soon as possible. Inevitably, some processes will be accelerated.
"I know all this, Mike, and I want a solution." Smith said, knocking on the table.
"It can be done in three steps at the same time. The company contacts people from relevant departments in various countries and asks them to strictly review the phase 3 clinical data of this Chinese biopharmaceutical company. Although the phase 2 clinical trial is very fast, the phase 3 and the launch of We still have room to operate in the approval process. In the second step, we can speed up the current progress of some of our company's mRNA vaccines, and finally we may be able to launch them before them. Finally, the company needs to approve some marketing expenses, and we will Contact some 'authoritative' people and media channels. We can give them some evidence and information. As long as we can convince the public not to trust this vaccine, even if it is on the market, not many people will be willing to take it. When the market It’s still ours.” Mike said seriously.
"Well, yes, then I will do as you say and explain this matter. I will give you one day to make a detailed plan and budget. At that time, I will hold a meeting and invite all relevant departments to join us. Also, well Investigate the background and resources of this Chinese Aiying Biological Company." Smith's frown relaxed.
"Understood, boss." Mike nodded and said quickly.
(End of chapter)
